← Leaderboards
Le Cong
Stanford University
$4,606,066
Attributed
$4,606,066
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,606,066 · 3
By mechanism
R35$2,759,125 · 1
R01$1,846,941 · 2
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Thomas None Quertermous$63,279,401
- Jesse M Engreitz$13,286,146
- Natalia Gomez-Ospina$1,035,180
- Yuichiro Takagi$3,306,865
- Michael Levitt$17,746,755
Others in their field
Other Emerging Leaders on “Crispr/Cas Technology”
- William H. Peranteau · Children'S Hosp Of Philadelphia$16,284,236
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,090,386
- Jacqueline K White · Jackson Laboratory$11,881,166
- Jesse M Engreitz · Stanford University$8,776,071
- Peng Jiang · Rutgers, The State Univ Of N.J.$6,578,144
- Yin Shen · University Of California, San Francisco$6,515,212
Research focus
Crispr/Cas TechnologyGenomeProteinsGenome EngineeringTechnologyCellsHuman DiseaseCell TypeEngineeringModalitySingle Nucleotide PolymorphismVariantClustered Regularly Interspaced Short Palindromic RepeatsGenesCollectionToxic EffectHuman GenomeSuccessBiological ModelsMalignant NeoplasmsAlzheimer&AposDesignModificationComplex
Grant awards (10)
Combinatorial Perturbation with Multi-Omics Readout to Dissect Etiology of Alzheimer's Disease Using Stem Cell and In Vivo Models$619,681
R01 · FY2025 · AG · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$473,100
R35 · FY2025 · HG · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$473,100
R35 · FY2024 · HG · contact PI
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening$417,908
R01 · FY2024 · GM · contact PI
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening$417,908
R01 · FY2023 · GM · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$473,100
R35 · FY2022 · HG · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$473,100
R35 · FY2021 · HG · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$393,625
R35 · FY2021 · HG · contact PI
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening$391,444
R01 · FY2021 · GM · contact PI
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9$473,100
R35 · FY2020 · HG · contact PI